Clinical trial
Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial
NCT01614041 is registered in ClinicalTrials.gov with Marubeni Pharmaceuticals (Suzhou) Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial
- Lead sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 10, 2012
- Completion date
- July 31, 2019
- Enrollment
- 274 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.